Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_assertion type Assertion NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_head.
- NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_assertion description "[RUNX1 mutations clustered in the intermediate-risk cytogenetic group (46 of 640, 7.2%; cytogenetically normal, 34 of 538, 6.3%), whereas they were less frequent in adverse-risk cytogenetics (five of 109, 4.6%) and absent in core-binding-factor AML (0 of 77) and acute promyelocytic leukemia (0 of 61).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_provenance.
- NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_assertion evidence source_evidence_literature NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_provenance.
- NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_assertion SIO_000772 21343560 NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_provenance.
- NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_assertion wasDerivedFrom befree-2016 NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_provenance.
- NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_assertion wasGeneratedBy ECO_0000203 NP874344.RAF4lJXYSSDC1Hx2_bEcd9CRoHRvDeeZCoIqDi228Ung0130_provenance.